Why the study?
Does EPIbeam provide accurate patient-specific pre-treatment quality assurance compared to MapCHECK3 for IMRT and VMAT plans?
Does EPIbeam provide accurate patient-specific pre-treatment quality assurance compared to MapCHECK3 for IMRT and VMAT plans?
EPIbeam is a clinically valid and reliable patient-specific pre-treatment QA system for treatment plans with field sizes up to 24x24 cm2, showing comparable or superior gamma passing rates to MapCHECK3.
Supports EPIbeam for VMAT QA; leaves open need for prospective multi-center validation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Yoon et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: